Per a press release from NCPA… Hydrocodone, at least for now, is not being rescheduled to become a C-II at the federal level. A few weeks ago Sen. Joe Manchin III (D-W.Va.) added such an amendment to the Prescription Drug User Fee Act (PDUFA)—the legislation that requires brand, and soon generic, manufacturers to help fund […]
Filed under: General Problems | Leave a Comment »